Conclusion:This study provides crucial insights into frailty profiles and mortality over a median follow-up of 402 days.Although sociodemographic and functional characteristics were comparable between groups, significant differences were observed in laboratory parameters, reflecting distinct physiological profiles that may influence treatment outcomes.HD patients showed greater frailty according to the Fried scale, without statistical significance, and all-cause mortality rates were similar between groups, suggesting that accurately measured frailty may not be a determining factor for survival differences in this cohort.Patient-centered care is essential to address risk factors before and during dialytic therapy.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Yun et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: